Operator: Good day, and thank you for standing by. Welcome to the Sight Sciences First Quarter 2024 Earnings Results Conference Call. At this time, all participants are in a listen-only mode.
Piper Sandler restated their neutral rating on shares of Sight Sciences (NASDAQ:SGHT – Free Report) in a research report released on Friday, Benzinga reports. The brokerage currently has a $6.00 target price on the stock, up from their previous target price of $5.00. Separately, Needham & Company LLC reaffirmed a hold rating on shares of […]
Shares of Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) have earned an average rating of “Hold” from the seven brokerages that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and one has assigned a buy recommendation to […]
MENLO PARK, Calif., April 29, 2024 Sight Sciences, Inc. , an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the.
Sight Sciences, Inc. (SGHT) said it received a positive jury trial verdict of $34 million associated with the patent infringement case it filed on September 16, 2021 against Alcon Inc.